Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosapride for Gut Transit in Constipation and IBS-C
NCT02433847Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- May 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of mosapride in chronic constipation, irritable bowel syndrome (IBS), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
mosapride
03
Conditions
chronic constipationirritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02433847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02433847.